Ryan M. Dunlap
2013
In 2013, Ryan M. Dunlap earned a total compensation of $684.4K as Vice President, Chief Financial Officer at Galena Biopharma.
Compensation breakdown
| Bonus | $41,000 |
|---|---|
| Option Awards | $448,016 |
| Salary | $195,028 |
| Other | $366 |
| Total | $684,410 |
Dunlap received $448K in option awards, accounting for 65% of the total pay in 2013.
Dunlap also received $41K in bonus, $195K in salary and $366 in other compensation.
Rankings
In 2013, Ryan M. Dunlap's compensation ranked 8,230th out of 12,286 executives tracked by ExecPay. In other words, Dunlap earned more than 33.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,230 out of 12,286 | 33rd |
Division Manufacturing | 2,983 out of 4,612 | 35th |
Major group Chemicals And Allied Products | 933 out of 1,462 | 36th |
Industry group Drugs | 708 out of 1,156 | 39th |
Industry Pharmaceutical Preparations | 560 out of 890 | 37th |
Source: SEC filing on June 3, 2016.
Dunlap's colleagues
We found one more compensation record of an executive who worked with Ryan M. Dunlap at Galena Biopharma in 2013.
2013
Mark Schwartz
Galena Biopharma